Yantai Zhenghai Biotechnology Co., Ltd.

SZSE:300653 Stock Report

Market Cap: CN¥3.9b

Yantai Zhenghai Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 300653?
Owner TypeNumber of SharesOwnership Percentage
State or Government754,4000.423%
Private Companies3,775,0002.12%
Institutions20,689,52111.6%
Individual Insiders74,773,37441.9%
General Public78,339,10543.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 56% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
34.2%
Bohai Mi
60,961,500CN¥1.3b0%no data
7.75%
Qun Dong
13,811,874CN¥302.1m0%no data
2.12%
Jiaxing Zhenghai Venture Capital Partnership Enterprise (Limited Partnership)
3,775,000CN¥82.6m0%no data
1.55%
Huaxia Life Insurance Co. Ltd, Asset Management Arm
2,760,900CN¥60.4m0%0.15%
1.33%
Fullgoal Fund Management Co. Ltd.
2,370,989CN¥51.9m0%0.02%
1.18%
Rui Life Insurance Co., LTD., Asset management arm
2,110,900CN¥46.2m0%no data
1.1%
E Fund Management Co., Ltd.
1,967,531CN¥43.0m0%0.01%
0.99%
National Council for Social Security Fund
1,772,697CN¥38.8m0%0.01%
0.84%
Taiping Fund Management Company Ltd.
1,503,406CN¥32.9m-11.7%0.45%
0.81%
New China Fund Management Co., Ltd.
1,447,125CN¥31.6m0%0.47%
0.8%
GF Fund Management Co., Ltd.
1,427,600CN¥31.2m0%0.01%
0.67%
China Life Asset Management Company Limited
1,197,947CN¥26.2m0%0.03%
0.5%
Rongtong Fund Management Co. Ltd.
892,100CN¥19.5m0%0.07%
0.47%
Kuwait Investment Authority
839,594CN¥18.4m0%0.01%
0.42%
Monetary Authority of Macao
754,400CN¥16.5m0%no data
0.4%
Invesco Ltd.
713,288CN¥15.6m0%no data
0.36%
China Southern Asset Management Co., Ltd.
636,916CN¥13.9m0%no data
0.18%
ICBC Credit Suisse Asset Management Co., Ltd.
313,850CN¥6.9m0%no data
0.16%
Maxwealth Fund Management Co., Ltd
288,768CN¥6.3m0%0.04%
0.076%
Dimensional Fund Advisors LP
135,400CN¥3.0m0%no data
0.04%
Everbright Pramerica Fund Management Co. Ltd.
70,800CN¥1.5m0%0.01%
0.017%
HFT Investment Management Co. Ltd. (Group)
30,710CN¥671.6k0%no data
0.016%
Tianhong Asset Management Co., Ltd.
27,800CN¥608.0k0%no data
0.015%
Huatai-PineBridge Fund Management Co., Ltd.
26,900CN¥588.1k0%no data
0.013%
China Merchants Fund Management Company Ltd.
23,825CN¥521.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 23:34
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yantai Zhenghai Biotechnology Co., Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yanyin ZhuChina International Capital Corporation Limited
Bin WuChina Merchants Securities Co. Ltd.
Wen DaiHuatai Research